图书简介
This open access book offers a comprehensive review of hepatocellular carcinoma (HCC) with a particular focus on the pathobiology and clinical aspects of the disease, including diagnosis and treatment. HCC is becoming one of the most common causes of cancer-related death worldwide. It is the fifth most common malignancy in men and the ninth in women, with an estimated 500,000 to 1 million new cases annually around the world. Independent of its cause, cirrhosis is considered a major clinical and histopathological risk factor for HCC development. Five percent of all cirrhotic patients develop HCC every year. Diagnostic tools for HCC include blood tests, high-quality imaging studies and liver biopsy. The treatment of HCC depends on the size and location of the HCC and includes surgical resection, liver transplantation, endovascular approaches, percutaneous ablation, and medical treatments. The book is organized into four parts – overview, diagnosis, management strategies, and recommendations – and aims to provide surgeons and clinicians with a valuable resource for complete and up-to-date research on the clinical aspects and management of HCC.
PART I: OVERVIEW.- Chapter 1. Epidemiological Aspects of Hepatocellular Carcinoma.- Chapter 2. Molecular and Genetic Mechanisms of Hepatocellular Carcinoma.- Chapter 3. Role of the Immune System in Hepatocellular Carcinoma.- Chapter 4. Underlying Liver Disease.- PART II: DIAGNOSIS.- Chapter 5. Imaging of Hepatocellular Carcinoma.- Chapter 6. Pathology of Hepatocellular Carcinoma.- Chapter 7. Hepatological Evaluation and Biomarkers.- PART III: TREATMENT.- Chapter 8. Percutaneous and Laparoscopic-Assisted Ablation of Hepatocellular Carcinoma.- Chapter 9. Endovascular Treatments of Hepatocellular Carcinoma.- Chapter 10. Indications for Surgery in Cirrhotic Patients.- Chapter 11. Laparoscopic Approach for the Treatment of Hepatocellular Carcinoma.- Chapter 12. Robotic Approach for the Treatment of Hepatocellular Carcinoma.- Chapter 13. Ultrasound-Guided Liver Resection and Parenchymal-Sparing Surgery.- Chapter 14. Surgical Margins for Hepatocellular Carcinoma.- Chapter 15. Major Hepatectomies for Hepatocellular Carcinoma.- Chapter 16. R1-Vascular Surgery for Hepatocellular Carcinoma.- Chapter 17. Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS).- Chapter 18. “Re-Do” Surgery for Hepatocellular Carcinoma: Indications and Results.- Chapter 19. Liver Transplantation for Hepatocellular Carcinoma.- Chapter 20. Downstaging Strategies Prior to Liver Transplantation.- Chapter 21. Hepatocellular Carcinoma Medical Therapy.- PART IV: SPECIAL CONSIDERATIONS.- Chapter 22. Surveillance for Patients at Risk of Developing Hepatocellular Carcinoma.- Chapter 23. Hepatocellular Carcinoma Recurrence: How to Manage.- Chapter 24. Liver Biopsy: How and When.- Chapter 25. Anesthesiologic Management During Surgery for Hepatocellular Carcinoma.
Trade Policy 买家须知
- 关于产品:
- ● 正版保障:本网站隶属于中国国际图书贸易集团公司,确保所有图书都是100%正版。
- ● 环保纸张:进口图书大多使用的都是环保轻型张,颜色偏黄,重量比较轻。
- ● 毛边版:即书翻页的地方,故意做成了参差不齐的样子,一般为精装版,更具收藏价值。
关于退换货:
- 由于预订产品的特殊性,采购订单正式发订后,买方不得无故取消全部或部分产品的订购。
- 由于进口图书的特殊性,发生以下情况的,请直接拒收货物,由快递返回:
- ● 外包装破损/发错货/少发货/图书外观破损/图书配件不全(例如:光盘等)
并请在工作日通过电话400-008-1110联系我们。
- 签收后,如发生以下情况,请在签收后的5个工作日内联系客服办理退换货:
- ● 缺页/错页/错印/脱线
关于发货时间:
- 一般情况下:
- ●【现货】 下单后48小时内由北京(库房)发出快递。
- ●【预订】【预售】下单后国外发货,到货时间预计5-8周左右,店铺默认中通快递,如需顺丰快递邮费到付。
- ● 需要开具发票的客户,发货时间可能在上述基础上再延后1-2个工作日(紧急发票需求,请联系010-68433105/3213);
- ● 如遇其他特殊原因,对发货时间有影响的,我们会第一时间在网站公告,敬请留意。
关于到货时间:
- 由于进口图书入境入库后,都是委托第三方快递发货,所以我们只能保证在规定时间内发出,但无法为您保证确切的到货时间。
- ● 主要城市一般2-4天
- ● 偏远地区一般4-7天
关于接听咨询电话的时间:
- 010-68433105/3213正常接听咨询电话的时间为:周一至周五上午8:30~下午5:00,周六、日及法定节假日休息,将无法接听来电,敬请谅解。
- 其它时间您也可以通过邮件联系我们:customer@readgo.cn,工作日会优先处理。
关于快递:
- ● 已付款订单:主要由中通、宅急送负责派送,订单进度查询请拨打010-68433105/3213。
本书暂无推荐
本书暂无推荐